SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and ...

All planned clinical studies in fasedienol U.S. registration-directed Phase 3 program for the acute treatment of social anxiety disorder are underway Vistagen (Nasdaq: VTGN), a late clinical-stage ...

Serious stress, anxiety, and fear are in the air and seem pervasive in our country and culture with symptoms seemingly getting worse by the day. This stress is fueled by a wide variety of national and ...

Imagine that you just got a bad job evaluation, or learned that your suspicious mole really might be cancer. Your heart races, your chest tightens, your mouth is cottony dry and your skin damp with ...

The Fresh Toast - Why anxiety feels worse than ever as Americans explore cannabis, stress relief, and new coping tools.

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...